Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling

Table 1 Primer sequences used in study

Gene name	Gene accession No.	Primer (5'→3')	Length (bp)
Lnc524369	ENST00000524369.1	F: CAGCAGAACTGGGTGTTGGA	90
		R: GCGCTGCAGTTTCCTCCTT
GAPDH	NM_002046.5	F: CCATGACAACTTTGGTATCGTGGAA	107
		R: GGCCATCACGCCACAGTTTC

Table 2 Hepatocellular carcinoma patients based on Lnc524369 levels

		Higher expression (n = 22)	Lower expression (n = 19)	t/χ2	P
Age		57.68 ± 10.77	54.21 ± 11.44	1.000	0.688
Male		13 (59.1%)	12 (63.16%)	0.004	0.952
Pathological grading	Low	9 (40.91%)	2 (10.53%)
	Moderate	11 (50.00%)	10 (52.63%)	-	0.009
	High	2 (9.09%)	7 (36.84%)

Fisher's exact test was used.